Is hydroxyzine contraindicated in patients with postural orthostatic tachycardia syndrome (POTS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hydroxyzine is NOT contraindicated in POTS

Hydroxyzine is not specifically contraindicated in patients with POTS, but it should be used with significant caution due to its QT-prolonging effects and potential to worsen orthostatic symptoms through sedation and CNS depression.

Key Concerns with Hydroxyzine in POTS

QT Prolongation Risk

The primary concern is that hydroxyzine is contraindicated in patients with prolonged QT interval 1. The FDA label explicitly warns that hydroxyzine can cause QT prolongation and Torsade de Pointes, particularly in patients with:

  • Pre-existing heart disease
  • Electrolyte imbalances
  • Concomitant use of other QT-prolonging medications 1

While POTS itself does not inherently cause QT prolongation, many patients with POTS are treated with medications that can affect the QT interval. The 2020 Canadian Cardiovascular Society guidelines list common POTS medications including beta-blockers, ivabradine, and various other agents 2. If a POTS patient is on any QT-prolonging medications (such as certain antiarrhythmics, antipsychotics, or antibiotics), adding hydroxyzine creates additional risk 1.

Sedation and Orthostatic Symptoms

Hydroxyzine causes significant CNS depression and drowsiness 1. This is problematic in POTS because:

  • Sedation may worsen the "brain fog" and cognitive impairment already common in POTS patients
  • CNS depressants can potentially impair compensatory mechanisms needed for orthostatic tolerance
  • The sedating effects may interfere with the exercise training programs that are strongly recommended for all POTS patients 2

Clinical Decision Algorithm

Before prescribing hydroxyzine to a POTS patient:

  1. Obtain a baseline ECG to rule out prolonged QT interval (if QTc >450ms in men or >470ms in women, hydroxyzine is contraindicated) 1

  2. Review all current medications for QT-prolonging agents - if present, avoid hydroxyzine or use extreme caution with ECG monitoring 1

  3. Check electrolytes (potassium, magnesium, calcium) - correct any abnormalities before considering hydroxyzine 1

  4. Consider the indication carefully - if hydroxyzine is being used for anxiety or sleep, alternative agents without QT effects may be preferable in POTS patients

  5. If hydroxyzine must be used:

    • Start at the lowest effective dose
    • Monitor for worsening orthostatic symptoms
    • Warn patients about increased drowsiness and avoid combining with other CNS depressants 1
    • Consider repeat ECG monitoring, especially if other risk factors are present

Important Caveats

The major POTS treatment guidelines 2 do not specifically address antihistamines like hydroxyzine, as they focus on medications that improve central blood volume, enhance vasoconstriction, or reduce sinus tachycardia. Hydroxyzine does none of these and may theoretically worsen symptoms through sedation.

The absolute contraindication is prolonged QT interval 1, not POTS itself. However, the overlap of risk factors (young women, potential electrolyte abnormalities from high salt intake and fludrocortisone use, polypharmacy) means POTS patients warrant extra scrutiny before hydroxyzine prescription.

Related Questions

In a typical young adult female with postural orthostatic tachycardia syndrome (POTS), is peripheral vasoconstriction beneficial as a treatment?
In a resource‑limited psychiatric hospital, what oral medications are appropriate for a patient with asthma, postural orthostatic tachycardia syndrome (POTS), and reactive hypoglycemia?
In a 15-year-old girl with postural orthostatic tachycardia syndrome (POTS) who is taking mirtazapine for decreased appetite and insomnia, how should the medication be managed regarding dosing, monitoring, and possible alternatives?
How should beta‑blockers be used to treat postural orthostatic tachycardia syndrome (POTS)?
Can patients with postural orthostatic tachycardia syndrome (POTS) use albuterol?
Is a cortisone (corticosteroid) intra‑articular knee injection contraindicated in a patient with atrial flutter?
After a fall causing a lumbar disc protrusion at L5‑S1, disc bulges at L5‑S1 and C5‑C6, and a vertebral hemangioma at T5, I now have burning mid‑back pain, right lower‑back pain, tingling in my arms and legs, foot drop, abdominal/right‑testicular pain, ear ringing, and joint crackling; what urgent evaluation and treatment should I pursue?
After ureteral stent removal, how long should pain and hematuria persist?
How should menopausal symptoms be evaluated and treated in a woman after total hysterectomy (with or without bilateral oophorectomy)?
What is the appropriate evaluation and management for a 16‑year‑old female with elevated DHEA‑Sulfate (dehydroepiandrosterone sulfate), elevated total testosterone, elevated free testosterone, and vitamin D deficiency?
Should a patient with esophageal cancer swallow magic mouthwash (a topical oral rinse containing diphenhydramine, lidocaine, antacids, sucralfate, and possibly corticosteroids)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.